Pharma Bio Category

Showing 301–330 of 429 results

• 
  SME

  NEXGEN Biotechnologies, Inc

  Second generation plant genetic technology

• 
  SME

  NGeneBio

  Cancer, immune system diseases, infectious diseases, nervous system diseases, and orthopedic diseases

• 
  SME

  NIBEC

  Target-selective tissue-delivery technology

• 
  SME

  NKCL Bio Group

  NKCL Bio Group Inc. is a bio company that researches and develops immune cell therapy using NK immune cells for cancer treatment and immunity enhancement.

• 
  Venture

  NKMAX

  Specialized biological research reagents for the biotech and health industries
  NKMAX’s proteins and antibodies development has stemmed from its stable-peptide (SP) fusion technology, which was originally designed to stabilize proteins susceptible to damage from its environment.
  NKMAX manufactures more than 5,000 different recombinant proteins and over 400 monoclonal antibodies being sold in over 38 countries around the world.

• 
  Venture

  Novacell

  Peptide-based biotherapeutics and biomaterials

• 
  Venture

  Novarex

• 
  Global

  Novartis Korea

  Healthcare

• 
  Diagnostics

  Novomics

• 
  Venture

  nSAGE

• 
  Venture

  NuclixBio

  Nucleic acid therapeutics

• 
  Venture

  OliPass

  Since 2006, OliPass has been committed to revolutionizing the life sciences and improving the quality of life. Our research is focused on developing a new generation of therapeutics using our novel PNA based technologies. Thanks to our dedicated team and their hard work, OliPass is now a leading biotech company with OliPass PNA Platform Technology and a growing presence throughout the globe.
  At OliPass, scientists from diverse fields are constantly working together to find the cures for all diseases. With our innovative OliPass PNA platform technology, our goal is to make the highest quality of science affordable and accessible, so that everyone around the world can enjoy a happy, healthy life. OliPass is dedicated to providing safe and feasible options for healthy aging.

• 
  Venture

  OliX Pharmaceuticals

  OliX Pharmaceuticals is a clinical stage pharmaceutical company developing therapeutics against a variety of disorders based on its proprietary RNAi technology.

• 
  Global

  Ono Pharm Korea Co., Ltd

  Fighting disease and pain

• 
  SME

  OPTUS Pharmaceutical Co., Ltd

  Ophthalmologicals

• 
  Venture

  Oscotec Inc.

  Novel antibody therapeutics

• 
  Venture

  PAEAN Biotechnology

  PAEAN Biotechnology strives to develop revolutionary first-in-class medicinal products through a proprietary platform based on the unique characteristics of mitochondria.

• 
  Venture

  Panagene

• 
  Venture

  PanGen Biotech, Inc.

  Novel antibody therapeutics

• 
  Diagnostics

  PCL, Inc.

  Construction of facilities associated with oil and gas production

• 
  Venture

  Peptron

  Novel antibody therapeutics for regenerative medicine

• 
  Global

  Pfizer Pharmaceutical Korea

  Biologics, small molecules, immunotherapies, and biosimilars

• 
  Venture

  PharmAbcine Inc

  Oncology antibody therapeutics

• 
  Large

  Pharmaking Co.,Ltd.

• 
  SME

  PharmaResearch Products Co., Ltd

  Novel antibody therapeutics for regenerative medicine

• 
  Venture

  PHARMBIO INC.

  Small molecule drugs

• 
  SME

  PHARMICELL Co., Ltd

  Stem cell therapy and immune cell therapy

• 
  Venture

  Pharos iBio Co., Ltd

  Treatments for refractory and rare diseases

• 
  Large

  PHARVIS KOREA

  Pharmaceutical

• 
  Venture

  Pinot Bio

  PinoBio is a company that focuses on the development of Antibody-Drug Conjugates (ADC) for cancer treatment.